Immediate Impact
2 from Science/Nature 62 standout
Citing Papers
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Crohn's disease
2024 Standout
Works of Maria Cappello being referenced
Inflammatory Bowel Disease Onset During Secukinumab Treatment: Real Concern or Just an Expression of Dysregulated Immune Response?
2019
Smoking habits and recurrence in Crohn's disease
1994
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Maria Cappello | 964 | 882 | 474 | 56 | 1.3k | |
| Satoru Umegae | 1221 | 920 | 644 | 53 | 1.5k | |
| Philippe Vergauwe | 797 | 779 | 526 | 48 | 1.6k | |
| G Holdstock | 491 | 541 | 556 | 48 | 1.4k | |
| Arthur Barrie | 938 | 799 | 442 | 83 | 1.5k | |
| Ioannis Mouzas | 573 | 469 | 689 | 53 | 1.6k | |
| Salvatore Greco | 638 | 575 | 626 | 77 | 1.7k | |
| Robert Battat | 1095 | 779 | 500 | 78 | 1.6k | |
| Gordon W. Moran | 898 | 686 | 525 | 93 | 1.5k | |
| Marc Schwartz | 995 | 839 | 449 | 76 | 1.4k | |
| Nynne Nyboe Andersen | 680 | 488 | 272 | 28 | 1.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...